Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Search Query
Submit Search
Show Search
Biomarin Pharmaceutical
Portfolio
Pharmaceutical Companies Gird for Drug-Price Reckoning
Uproar over suddenly hiked-up medications may not crush health care stocks for long, but it does force the industry to justify value.
Kaitlin Ugolik
October 8, 2015
Premium
Tourbillon Thrives on a Heady Mix of PR and Performance
Jason Karp’s still-young hedge fund firm generates big numbers with an unusual long-short strategy — and a CIA interrogator.
Stephen Taub
June 9, 2015